Barclays analyst Emily Field upgrades GlaxoSmithKline (NYSE:GSK) from Underweight to Equal-Weight.
Ubiquiti Q4 Adj. EPS $2.47 Beats $2.34 Estimate, Sales $477.90M Beat $463.93M Estimate
Ubiquiti (NYSE:UI) reported quarterly earnings of $2.47 per share which beat the analyst consensus estimate of $2.34 by 5.56 percent. This is a 69.18 percent increase over earnings of $1.46 per share from the same period